MILRINONE LACTATE

MILRINONE LACTATE was reported 277 times

MILRINONE LACTATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLATELET AGGREGATION INHIBITION 4 0.0435
1 BURKHOLDERIA TEST POSITIVE 3 0.0242
2 WHITE CLOT SYNDROME 1 0.0233
3 PATENT DUCTUS ARTERIOSUS REPAIR 1 0.0208
4 ILIAC VEIN OCCLUSION 1 0.0164
5 VENOUS OXYGEN SATURATION DECREASED 1 0.0141
6 FISHBANE REACTION 1 0.0128
7 SERRATIA TEST POSITIVE 1 0.0103
8 CARDIAC INDEX DECREASED 1 0.0097
9 CENTRAL VENOUS PRESSURE INCREASED 1 0.0082
10 STENOTROPHOMONAS TEST POSITIVE 1 0.0075
11 MYOCARDIAL STUNNING 1 0.0075
12 THORACOTOMY 1 0.0070
13 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
14 ATRIOVENTRICULAR DISSOCIATION 1 0.0047
15 RIGHT-TO-LEFT CARDIAC SHUNT 1 0.0045
16 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
17 CULTURE STOOL POSITIVE 1 0.0036
18 ANGIOGRAM 1 0.0036
19 SECONDARY HYPERTENSION 1 0.0035
20 RIGHT VENTRICULAR ENLARGEMENT 1 0.0031
21 OXYGEN SATURATION INCREASED 1 0.0029
22 PULMONARY ARTERY DILATATION 1 0.0029
23 TRACHEAL HAEMORRHAGE 1 0.0028
24 CATHETER REMOVAL 1 0.0028
25 EOSINOPHILIC MYOCARDITIS 2 0.0027
26 NEONATAL HYPOTENSION 1 0.0027
27 RESPIRATORY GAS EXCHANGE DISORDER 1 0.0027
28 PRODUCT LABEL ON WRONG PRODUCT 1 0.0025
29 SPUTUM CULTURE POSITIVE 2 0.0025
30 CARDIAC VENTRICULAR DISORDER 1 0.0024
31 COR PULMONALE 2 0.0021
32 PO2 INCREASED 1 0.0020
33 HYPERTROPHY 1 0.0018
34 RETINOPATHY OF PREMATURITY 1 0.0018
35 LIFE EXPECTANCY SHORTENED 1 0.0018
36 ESCHERICHIA TEST POSITIVE 2 0.0017
37 ENTEROCOCCUS TEST POSITIVE 1 0.0015
38 ISCHAEMIC HEPATITIS 2 0.0015
39 ECHOCARDIOGRAM ABNORMAL 2 0.0014
40 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
41 PROPOFOL INFUSION SYNDROME 1 0.0014
42 SERRATIA INFECTION 1 0.0013
43 ASPIRATION PLEURAL CAVITY 1 0.0013
44 CROUP INFECTIOUS 1 0.0013
45 ENTEROCOCCAL SEPSIS 1 0.0012
46 PSEUDOMONAS TEST POSITIVE 1 0.0012
47 AORTIC VALVE INCOMPETENCE 5 0.0012
48 PSEUDOMONAL BACTERAEMIA 1 0.0012
49 VASOCONSTRICTION 1 0.0011
50 CARDIAC OUTPUT DECREASED 1 0.0011
51 HEART TRANSPLANT 1 0.0011
52 VASOSPASM 1 0.0011
53 PRODUCT APPEARANCE CONFUSION 1 0.0011
54 CATHETER RELATED INFECTION 1 0.0010
55 HEART TRANSPLANT REJECTION 1 0.0010
56 ATRIAL TACHYCARDIA 2 0.0010
57 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
58 CLOSTRIDIUM TEST POSITIVE 2 0.0009
59 AORTIC DILATATION 1 0.0009
60 MYOCARDIAL INJURY 1 0.0009
61 KLEBSIELLA SEPSIS 1 0.0009
62 SICK SINUS SYNDROME 1 0.0009
63 AORTIC THROMBOSIS 1 0.0009
64 PAROTITIS 1 0.0009
65 RIGHT VENTRICULAR FAILURE 6 0.0009
66 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
67 CARDIAC DYSFUNCTION 3 0.0008
68 VENTRICULAR HYPERTROPHY 2 0.0008
69 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
70 POLYTRAUMATISM 1 0.0007
71 CARDIOVERSION 1 0.0007
72 ENDOTRACHEAL INTUBATION 2 0.0007
73 CULTURE URINE POSITIVE 1 0.0007
74 CARDIAC FAILURE CHRONIC 3 0.0007
75 NODAL RHYTHM 1 0.0007
76 SKIN STRIAE 1 0.0007
77 MYOGLOBIN BLOOD INCREASED 1 0.0007
78 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
79 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
80 VASOPLEGIA SYNDROME 1 0.0006
81 VENTRICULAR TACHYCARDIA 10 0.0006
82 RESUSCITATION 1 0.0006
83 PATHOLOGICAL GAMBLING 1 0.0006
84 VENA CAVA THROMBOSIS 1 0.0006
85 TROPONIN I INCREASED 1 0.0006
86 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
87 BLOOD PH DECREASED 1 0.0006
88 BLOOD AMYLASE INCREASED 1 0.0006
89 PSEUDOMONAL SEPSIS 1 0.0006
90 X-RAY ABNORMAL 1 0.0006
91 CARDIOGENIC SHOCK 8 0.0006
92 PNEUMONIA KLEBSIELLA 1 0.0005
93 PUPILLARY REFLEX IMPAIRED 1 0.0005
94 MECHANICAL VENTILATION 1 0.0005
95 MULTI-ORGAN FAILURE 9 0.0005
96 CORONARY ARTERY THROMBOSIS 1 0.0005
97 FOAMING AT MOUTH 1 0.0005
98 LIBIDO INCREASED 1 0.0005
99 ATRIAL THROMBOSIS 1 0.0005
100 CONGESTIVE CARDIOMYOPATHY 2 0.0005
101 DILATATION VENTRICULAR 1 0.0005
102 FEAR OF DEATH 1 0.0004
103 KOUNIS SYNDROME 1 0.0004
104 DYSMORPHISM 1 0.0004
105 PULSE ABSENT 2 0.0004
106 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
107 STARING 1 0.0004
108 PRODUCT PACKAGING CONFUSION 1 0.0004
109 TRANSPLANT FAILURE 1 0.0004
110 HEART INJURY 1 0.0004
111 TACHYARRHYTHMIA 1 0.0004
112 STEM CELL TRANSPLANT 1 0.0004
113 RETINAL ARTERY OCCLUSION 1 0.0004
114 RENAL FAILURE CHRONIC 3 0.0004
115 VENTRICULAR DYSFUNCTION 1 0.0004
116 TRICUSPID VALVE INCOMPETENCE 3 0.0004
117 LUNG CONSOLIDATION 1 0.0004
118 REBOUND EFFECT 4 0.0004
119 DIALYSIS 5 0.0004
120 PRODUCT LABEL CONFUSION 2 0.0003
121 LUNG INFILTRATION 3 0.0003
122 INTRACARDIAC THROMBUS 1 0.0003
123 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
124 DIASTOLIC DYSFUNCTION 1 0.0003
125 OLIGURIA 2 0.0003
126 RESPIRATORY RATE DECREASED 1 0.0003
127 PNEUMONIA VIRAL 1 0.0003
128 VENTRICULAR HYPOKINESIA 1 0.0003
129 SHOCK 7 0.0003
130 PULMONARY CONGESTION 4 0.0003
131 PEPTIC ULCER 1 0.0003
132 CARDIAC FAILURE ACUTE 2 0.0003
133 THERAPEUTIC AGENT TOXICITY 1 0.0003
134 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
135 CLOSTRIDIAL INFECTION 1 0.0003
136 LEFT VENTRICULAR FAILURE 1 0.0003
137 AORTIC STENOSIS 1 0.0003
138 BRONCHIOLITIS 1 0.0003
139 LUNG TRANSPLANT 1 0.0003
140 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
141 VENTRICULAR ARRHYTHMIA 1 0.0003
142 MITRAL VALVE INCOMPETENCE 3 0.0003
143 ACIDOSIS 2 0.0003
144 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
145 POST PROCEDURAL HAEMORRHAGE 3 0.0003
146 RHINOVIRUS INFECTION 1 0.0003
147 APNOEA 2 0.0003
148 PULMONARY HAEMORRHAGE 2 0.0003
149 VENOUS THROMBOSIS 1 0.0003
150 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
151 ARTERIOSPASM CORONARY 1 0.0002
152 ORGAN FAILURE 1 0.0002
153 EXTRAVASATION 1 0.0002
154 PULMONARY HYPERTENSION 5 0.0002
155 HAEMODIALYSIS 2 0.0002
156 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
157 UTERINE HAEMORRHAGE 1 0.0002
158 ANURIA 2 0.0002
159 CATHETERISATION CARDIAC 1 0.0002
160 LIMB OPERATION 1 0.0002
161 ATELECTASIS 2 0.0002
162 ENTEROCOCCAL INFECTION 1 0.0002
163 FLUID OVERLOAD 3 0.0002
164 HYPERVOLAEMIA 1 0.0002
165 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
166 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
167 VENTRICULAR EXTRASYSTOLES 2 0.0002
168 BLOOD LACTIC ACID INCREASED 1 0.0002
169 RENAL FAILURE ACUTE 8 0.0002
170 ASPIRATION 2 0.0002
171 VENTRICULAR FIBRILLATION 2 0.0002
172 INTRACRANIAL PRESSURE INCREASED 1 0.0002
173 MALNUTRITION 2 0.0002
174 ANGIOPATHY 1 0.0002
175 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
176 CHOLECYSTITIS ACUTE 1 0.0002
177 GENERALISED ERYTHEMA 1 0.0002
178 CARDIAC VALVE DISEASE 1 0.0002
179 METABOLIC DISORDER 1 0.0002
180 FOETAL GROWTH RESTRICTION 1 0.0002
181 SMALL INTESTINAL OBSTRUCTION 2 0.0002
182 POST PROCEDURAL COMPLICATION 3 0.0002
183 PRODUCT PREPARATION ISSUE 1 0.0002
184 ANHEDONIA 4 0.0002
185 CARDIAC FAILURE 12 0.0001
186 FEAR 4 0.0001
187 WRONG PRODUCT ADMINISTERED 1 0.0001
188 RESPIRATION ABNORMAL 1 0.0001
189 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
190 HEPATOCELLULAR INJURY 2 0.0001
191 SUBDURAL HAEMATOMA 2 0.0001
192 CARDIOMYOPATHY 2 0.0001
193 RENAL INJURY 4 0.0001
194 PULMONARY OEDEMA 6 0.0001
195 HAEMODYNAMIC INSTABILITY 1 0.0001
196 PROCEDURAL COMPLICATION 1 0.0001
197 EJECTION FRACTION DECREASED 2 0.0001
198 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
199 PNEUMOTHORAX 2 0.0001
200 ATRIAL FLUTTER 1 0.0001
201 TRANSPLANT REJECTION 1 0.0001
202 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
203 MYASTHENIA GRAVIS 1 0.0001
204 RESPIRATORY FAILURE 9 0.0001
205 POLYURIA 1 0.0001
206 CARDIAC ARREST 10 0.0001
207 EMBOLISM 1 0.0001
208 COAGULOPATHY 2 0.0001
209 CIRCULATORY COLLAPSE 2 0.0001
210 CARDIAC MURMUR 1 0.0001
211 HYPOXIA 4 0.0001
212 RESPIRATORY RATE INCREASED 1 0.0001
213 WRONG DRUG ADMINISTERED 1 0.0001
214 CARDIOTOXICITY 1 0.0001
215 THERAPY NON-RESPONDER 5 0.0001
216 RESPIRATORY DISTRESS 3 0.0001
217 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
218 SINUS BRADYCARDIA 1 0.0001
219 RENAL TUBULAR NECROSIS 1 0.0001
220 HAEMATOCRIT DECREASED 2 0.0001
221 CARDIAC FAILURE CONGESTIVE 8 0.0001
222 INJURY 7 0.0001
223 HEPATIC FAILURE 3 0.0001
224 EYELID PTOSIS 1 0.0001
225 RENAL FAILURE 13 0.0001
226 HYPERBILIRUBINAEMIA 1 0.0001
227 CARDIO-RESPIRATORY ARREST 4 0.0001
228 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
229 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
230 OXYGEN SATURATION DECREASED 5 0.0001
231 MYOCARDIAL ISCHAEMIA 1 0.0001
232 DERMATITIS CONTACT 1 0.0001
233 MYOCARDITIS 1 0.0001
234 HAEMORRHAGE 9 0.0001
235 BACTERAEMIA 1 0.0001
236 ACCIDENT 1 0.0001
237 NO THERAPEUTIC RESPONSE 1 0.0001
238 CARDIOMEGALY 1 0.0001
239 GENERALISED OEDEMA 1 0.0001
240 ILEUS 1 0.0001
241 HEPATIC FUNCTION ABNORMAL 3 0.0001
242 HYPOTENSION 16 0.0001
243 BRAIN OEDEMA 1 0.0001
244 TACHYCARDIA 7 0.0001
245 HAEMATOMA 2 0.0001
246 RESPIRATORY TRACT INFECTION 2 0.0001
247 OEDEMA 4 0.0001
248 TACHYPNOEA 1 0.0001
249 MENTAL STATUS CHANGES 2 0.0001
250 DEMENTIA 2 0.0001
251 SINUS TACHYCARDIA 1 0.0001
252 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
253 SEPTIC SHOCK 3 0.0001
254 ASCITES 2 0.0001
255 DRUG INEFFECTIVE 89 0.0001
256 UNEVALUABLE EVENT 5 0.0001
257 ECONOMIC PROBLEM 1 0.0001
258 PLEURAL EFFUSION 4 0.0001
259 DEVICE FAILURE 1 0.0001
260 DRUG DISPENSING ERROR 1 0.0001
261 CARDIAC DISORDER 6 0.0001
262 CYANOSIS 1 0.0001
263 RESPIRATORY TRACT CONGESTION 1 0.0001
264 BLOOD POTASSIUM INCREASED 1 0.0001
265 STAPHYLOCOCCAL INFECTION 2 0.0001
266 VIRAL INFECTION 2 0.0001
267 FLUID RETENTION 3 0.0001
268 ORTHOSTATIC HYPOTENSION 1 0.0001
269 EOSINOPHILIA 1 0.0001
270 BRADYCARDIA 3 0.0001
271 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
272 DRUG ERUPTION 1 0.0001
273 LEUKOCYTOSIS 1 0.0001
274 DYSURIA 2 0.0001
275 MEDICATION ERROR 3 0.0001
276 MIDDLE INSOMNIA 1 0.0001
277 BLOOD SODIUM DECREASED 1 0.0001
278 SLEEP APNOEA SYNDROME 1 0.0001
279 CHOLESTASIS 1 0.0001
280 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
281 ATRIAL FIBRILLATION 5 0.0001
282 DISABILITY 1 0.0001
283 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
284 UPPER LIMB FRACTURE 1 0.0001
285 CYTOKINE RELEASE SYNDROME 1 0.0000
286 PERITONITIS 1 0.0000
287 RENAL IMPAIRMENT 4 0.0000
288 LOSS OF CONSCIOUSNESS 6 0.0000
289 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
290 STEVENS-JOHNSON SYNDROME 1 0.0000
291 SEPSIS 5 0.0000
292 PERICARDIAL EFFUSION 1 0.0000
293 RENAL DISORDER 2 0.0000
294 DEVICE MALFUNCTION 3 0.0000
295 ARRHYTHMIA 2 0.0000
296 BLOOD PRESSURE FLUCTUATION 1 0.0000
297 EMOTIONAL DISTRESS 5 0.0000
298 MENTAL IMPAIRMENT 1 0.0000
299 LIVER INJURY 1 0.0000
300 HAEMATEMESIS 1 0.0000
301 HYPOPHAGIA 1 0.0000
302 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
303 ANAPHYLACTIC SHOCK 1 0.0000
304 UNRESPONSIVE TO STIMULI 1 0.0000
305 RASH GENERALISED 1 0.0000
306 PAIN OF SKIN 1 0.0000
307 RESPIRATORY ARREST 1 0.0000
308 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
309 HAEMOPTYSIS 1 0.0000
310 WOUND 1 0.0000
311 HYPONATRAEMIA 2 0.0000
312 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
313 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
314 CONVULSION 2 0.0000
315 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
316 LIVER FUNCTION TEST ABNORMAL 1 0.0000
317 CHILLS 4 0.0000
318 ACUTE MYOCARDIAL INFARCTION 1 0.0000
319 LABORATORY TEST ABNORMAL 1 0.0000
320 URINARY INCONTINENCE 1 0.0000
321 WHEEZING 2 0.0000
322 BLOOD POTASSIUM DECREASED 1 0.0000
323 CORONARY ARTERY DISEASE 1 0.0000
324 ACUTE KIDNEY INJURY 5 0.0000
325 EMOTIONAL DISORDER 1 0.0000
326 CHEST PAIN 6 0.0000
327 METABOLIC ACIDOSIS 1 0.0000
328 HIP FRACTURE 1 0.0000
329 LACTIC ACIDOSIS 1 0.0000
330 DEEP VEIN THROMBOSIS 2 0.0000
331 BLOOD PRESSURE DECREASED 2 0.0000
332 SYNCOPE 3 0.0000
333 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
334 HAEMOGLOBIN DECREASED 3 0.0000
335 HYPERKALAEMIA 1 0.0000
336 HEART RATE DECREASED 1 0.0000
337 PLATELET COUNT DECREASED 3 0.0000
338 CEREBRAL HAEMORRHAGE 1 0.0000
339 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
340 CRYING 1 0.0000
341 THROMBOCYTOPENIA 3 0.0000
342 PYREXIA 9 0.0000
343 THROMBOSIS 2 0.0000
344 OEDEMA PERIPHERAL 3 0.0000
345 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
346 TREATMENT FAILURE 2 0.0000
347 RHABDOMYOLYSIS 1 0.0000
348 ABDOMINAL DISCOMFORT 4 0.0000
349 HYPERHIDROSIS 3 0.0000
350 RECTAL HAEMORRHAGE 1 0.0000
351 MYOCARDIAL INFARCTION 4 0.0000
352 LIVER DISORDER 1 0.0000
353 NEUTROPENIA 3 0.0000
354 PNEUMONIA 7 0.0000
355 PRODUCTIVE COUGH 1 0.0000
356 RASH ERYTHEMATOUS 1 0.0000
357 HYPOGLYCAEMIA 1 0.0000
358 HEART RATE INCREASED 2 0.0000
359 FLUSHING 2 0.0000
360 DYSPNOEA 11 0.0000
361 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
362 NERVOUSNESS 1 0.0000
363 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
364 TREATMENT NONCOMPLIANCE 1 0.0000
365 HAEMATOCHEZIA 1 0.0000
366 PANCYTOPENIA 1 0.0000
367 ANXIETY 5 0.0000
368 HERPES ZOSTER 1 0.0000
369 LETHARGY 1 0.0000
370 SEIZURE 2 0.0000
371 ABDOMINAL PAIN 4 0.0000
372 DISEASE PROGRESSION 2 0.0000
373 JOINT SWELLING 2 0.0000
374 ILL-DEFINED DISORDER 1 0.0000
375 DISCOMFORT 1 0.0000
376 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
377 EXPOSURE DURING PREGNANCY 1 0.0000
378 PRODUCT USE ISSUE 3 0.0000
379 BLOOD CREATININE INCREASED 1 0.0000
380 FALL 5 0.0000
381 DEHYDRATION 2 0.0000
382 COUGH 4 0.0000
383 HYPERTENSION 3 0.0000
384 AGITATION 1 0.0000
385 BRONCHITIS 1 0.0000
386 DYSGEUSIA 1 0.0000
387 WEIGHT INCREASED 3 0.0000
388 DEPRESSION 3 0.0000
389 CHRONIC KIDNEY DISEASE 1 0.0000
390 PAIN 8 0.0000
391 VOMITING 6 0.0000
392 DRUG INTERACTION 2 0.0000
393 DRUG DEPENDENCE 2 0.0000
394 INFLUENZA LIKE ILLNESS 1 0.0000
395 TOXICITY TO VARIOUS AGENTS 2 0.0000
396 SKIN EXFOLIATION 1 0.0000
397 OFF LABEL USE 10 0.0000
398 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
399 MUSCULOSKELETAL STIFFNESS 1 0.0000
400 COVID-19 2 0.0000
401 NAUSEA 9 0.0000
402 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
403 ADVERSE EVENT 1 0.0000
404 HYPERSENSITIVITY 2 0.0000
405 SWELLING 1 0.0000
406 PULMONARY EMBOLISM 1 0.0000
407 ANAEMIA 2 0.0000
408 GAIT DISTURBANCE 2 0.0000
409 CONTUSION 1 0.0000
410 DRUG INTOLERANCE 1 0.0000
411 CONDITION AGGRAVATED 3 0.0000
412 ABDOMINAL DISTENSION 1 0.0000
413 OVERDOSE 2 0.0000
414 MALAISE 4 0.0000
415 DEATH 7 0.0000
416 ASTHENIA 3 0.0000
417 INFECTION 1 0.0000
418 HOSPITALISATION 1 0.0000
419 PERIPHERAL SWELLING 1 0.0000
420 PARAESTHESIA 1 0.0000
421 DIZZINESS 3 0.0000
422 URTICARIA 1 0.0000
423 CEREBROVASCULAR ACCIDENT 1 0.0000
424 BLOOD GLUCOSE INCREASED 1 0.0000
425 ERYTHEMA 1 0.0000
426 ABDOMINAL PAIN UPPER 1 0.0000
427 HEADACHE 3 0.0000
428 DECREASED APPETITE 1 0.0000
429 FEELING ABNORMAL 1 0.0000
430 DIARRHOEA 2 0.0000
431 PRURITUS 1 0.0000
432 FATIGUE 2 0.0000
433 ARTHRALGIA 1 0.0000
434 RASH 1 0.0000